argenx SE (EBR:ARGX)
584.20
-10.20 (-1.72%)
Aug 1, 2025, 5:35 PM CET
argenx SE Revenue
argenx SE had revenue of $967.19M USD in the quarter ending June 30, 2025, with 97.62% growth. This brings the company's revenue in the last twelve months to $3.12B, up 88.04% year-over-year. In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth.
Revenue (ttm)
$3.12B
Revenue Growth
+88.04%
P/S Ratio
13.45
Revenue / Employee
$1.95M
Employees
1,599
Market Cap
35.75B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.25B | 979.61M | 77.22% |
Dec 31, 2023 | 1.27B | 827.58M | 187.66% |
Dec 31, 2022 | 441.01M | -87.25M | -16.52% |
Dec 31, 2021 | 528.27M | 466.31M | 752.59% |
Dec 31, 2020 | 61.96M | -30.85M | -33.24% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UCB SA | 6.85B |
Financière de Tubize | 13.26K |
Fagron NV | 918.75M |
Ion Beam Applications | 498.16M |
Nyxoah | 4.36M |
Hyloris Pharmaceuticals | 9.76M |
Onward Medical | 1.74M |
Sequana Medical NV | 105.50K |
argenx SE News
- 2 days ago - argenx SE (ARGX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX - PRNewsWire
- 2 days ago - argenx SE GAAP EPS of $6.32 beats by $0.83, revenue of $1.74B beats by $50M - Seeking Alpha
- 2 days ago - argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update - GlobeNewsWire
- 3 days ago - argenx SE 1H 2025 Earnings Preview - Seeking Alpha
- 5 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX - GlobeNewsWire
- 6 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX - PRNewsWire
- 9 days ago - argenx to Report Half Year 2025 Financial Results and Second Quarter Business Update on July 31, 2025 - GlobeNewsWire